期刊文献+

急性心肌梗死治疗预后的影响因素分析 被引量:9

下载PDF
导出
摘要 目的研究急性心肌梗死患者实施治疗后的对预后产生影响的因素。方法选择我院2012年4月-2013年4月间诊治的176例急性心肌梗死患者,根据其最终结局分为两组,分别为死亡组和存活组,对两组患者的临床资料进行分析,同时运用Logistic回归分析可能对心肌梗死产生影响的因素。结果通过对所选的患者进行Logistic回归分析,对急性心肌梗死治疗预后产生影响的因素主要有胸痛至溶栓时间、年龄、前壁心梗、心力衰竭、吸烟史,OR值分别为8.44、8.25、6.22、5.98、5.33,同时随着OR值的增加,危险的相关性也随着升高。结论急性心肌梗死患者实施治疗后预后效果受到很多因素的影响,应根据具体的因素实施有针对性的预防措施,提升患者的预后效果。
作者 荣继平
机构地区 扶余市人民医院
出处 《中国继续医学教育》 2014年第6期32-33,共2页 China Continuing Medical Education
  • 相关文献

参考文献3

二级参考文献41

  • 1Barka T, van der Noen H. Expression of the eysteine proteinase inhibitor cystatin C gene in rat heart: use of digoxigenin-labeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations [J].J Histochem Cytochem, 1993,41(12) :1863-1867.
  • 2Filler G, Bokenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR-history, indications, and future research[J]. Clin Biochem,2005,38(1) : 1-8.
  • 3Shlipak MG, Katz R, Kestenbaum B, et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly[J]. Atherosclerosis, 2009,204 (1) : 298-303.
  • 4Ix JH,Shlipak MG,Chertow GM,et al. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease., data from the Heart and Soul Study[J].Circulation, 2007,115 (2) : 173- 179.
  • 5Derzhko R;Plaksej R,Przewlocka-Kosmala M,et al. Prediction of left ventricular dysfunction progression in patients with a first ST-elevation myocardial infarction-contribution of cystatin C assessment[J].Coron Artery Dis,2009,20(7):453-461.
  • 6Kilic T, Oner G, Ural E, et al. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome [J]. Atherosclerosis, 2009,207 (2) : 552-558.
  • 7Garcia Acuna JM, Gonzalez-Babarro E, Grigorian Shamagian L, et al. Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome[J]. Rev Esp Cardiol,2009,62(5) :510-519.
  • 8Windhausen F, Hirsch A, Fischer J, et al. Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T[J]. Clin Chem,2009,55(6) :1118-1125.
  • 9Kiyosue A, Hirata Y, Ando J, et al. Plasma eystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease[J]. Circ J, 2010, 74 (11):2441-2447.
  • 10Orso F, Maggioni AP. What is the optimal reperfusion strategy for elderly pa- tients with acute MI[J] ? Am J Geriatr Cardiol, 2006, 15:14-18.

共引文献36

同被引文献34

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部